Is it okay to only take lamivudine and dolutegravir tablets (Dovito) for AIDS?
Lamivudine/Dolutegravir (Lamivudine/Dolutegravir) is usually not the drug of choice as monotherapy for HIV infection. Treating an HIV infection usually involves using a combination of several different classes of anti-HIV drugs, called highly active antiretroviral therapy (Highly Active Antiretroviral Therapy, HAART) or antiretroviral combination therapy (Antiretroviral Combination Therapy, ART).
Lamivudine Dolutegravir tablets contain lamivudine (Lamivudine) and dolutegravir (Dolutegravir). These two drugs have different mechanisms of action and can work synergistically to inhibit the replication of HIV viruses. Lamivudine dolutegravir alone may not be effective enough to control HIV infection because HIV has the ability to mutate rapidly, which may lead to drug resistance.

Treatment ofHIVinfection therefore requires a selection of antiHIV drugs from many different classes to minimize the risk of viral replication and drug resistance. Treatment options are typically determined by a medical professional based on the patient's condition, drug resistance test results, and individual needs. Only by using drugs according to a complete treatment plan under the guidance of a professional physician can HIV infection be effectively managed, reduce viral load, maintain immune system function, and improve quality of life.
If you are worried or have concerns, it is recommended that you consult a medical professional immediately so they can develop an HIV treatment plan that is appropriate for you. Continuing to follow your doctor's advice and being monitored regularly are keys to successfully managing your HIV infection.
Lamivudine dolutegravir tablets have been launched in China and have been included in medical insurance. Patients can buy them in domestic hospital pharmacies at a price of about more than 1,000 yuan. Please consult the local hospital pharmacy for specific prices and reimbursement information. The cheaper ones abroad are mainly Indian generic drugs, which cost more than 200 yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)